Ryancoates (Talk | contribs) |
|||
Line 36: | Line 36: | ||
</table> | </table> | ||
</center> | </center> | ||
− | <br><br><br< | + | <br><br><br> |
+ | |||
+ | <p><img width=10% src="https://static.igem.org/mediawiki/2016/4/4b/T--Cardiff_Wales--Gold.png"/></p> | ||
+ | <h2>Gold</h2> | ||
+ | <br> | ||
+ | <p><b>1. Integrated Human Practices:</b> Our <a href=”https://2017.igem.org/Team:Cardiff_Wales/Human_Practices”>Human Practices page</a> that describes how we took the information we obtained from our survey (LINK) and subsequent interactions we had with worldwide group of scientists to better understand the potential of using plant expression systems for the production of pharmeuticals. THIS XXXXXX</p> | ||
+ | <br> | ||
+ | <p><b>2. Improve a previous part or project:</b> The <a href=”https://2016.igem.org/Resources/Plant_Synthetic_Biology/PhytoBricks”>iGEM Phytobricks</a> are present in the registry just as individual level 0 parts. We generated and characterised a composite part (XXXX) that allows for the expression of luciferase in the <i>Nicotiana benthamiana</i> leaf expression system. This construct can serve as a perfect control for subsequent experiments in this experiment system. The constitutively expressed PART XXXX can be used alongside other novel constructs to demonstrate the effectiveness of different leaf transformations, a process that is highly variable. This composite part is therefore extremely useful for any future users of phytobricks who are using luciferase expression as an output. | ||
+ | </p><br> | ||
+ | <p><b>3. Model your project:</b> The | ||
+ | </p> | ||
+ | |||
+ | <hr> | ||
+ | <center> | ||
+ | |||
</body> | </body> | ||
</html> | </html> |
Revision as of 14:18, 13 October 2017